SS
NUVB icon

SBI Securities’s Nuvation Bio NUVB Stock Holding History

SBI Securities’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.85K Buy
1,382
+354
+34% +$1.73K ﹤0.01% 1955
2026
Q1 		$4.41K Buy
1,028
+7
+0.7% +$39 ﹤0.01% 2083
2025
Q4 		$9.15K Buy
1,021
+2
+0.2% +$12 ﹤0.01% 1746
2025
Q3 		$3.77K Buy
1,019
+817
+404% +$2.23K ﹤0.01% 2165
2025
Q2 		$394 Buy
202
+201
+20,100% +$419 ﹤0.01% 3062
2025
Q1 		$2 Hold
1
– – ﹤0.01% 4094
2024
Q4 		$3 Buy
+1
New +$3 ﹤0.01% 4040

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

SBI Securities's NUVB Position: Q2 2026 in Review

SBI Securities increased its Nuvation Bio (NUVB) stake by 34% in Q2 2026, buying an estimated $1.73K and bringing the position to 1,382 shares worth $7.85K. The position accounts for ﹤0.01% of the portfolio, ranked #1955.

SBI Securities first reported a position in NUVB in Q4 2024 and has held it in 7 quarters since. The position peaked at $9.15K in Q4 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • SBI Securities held 1,382 shares of Nuvation Bio worth $7.85K as of Q2 2026.
  • SBI Securities bought 354 Nuvation Bio shares in Q2 2026, an estimated $1.73K.
  • Nuvation Bio made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #1955 holding.
  • SBI Securities first reported a position in Nuvation Bio in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Nuvation Bio position peaked at $9.15K in Q4 2025.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.